United Natural Foods stock price target raised by UBS to $42 from $29

United Natural Foods (UNFI) received price target upgrades from both UBS (to $42, Neutral) and BMO Capital (to $48, Outperform) following stronger-than-anticipated Q4 earnings and robust operational execution. Analysts cited improved profitability, free cash flow, and upwardly revised EBITDA forecasts, despite a planned customer exit impacting FY26 revenue. The stock's significant 71.31% annual return and near 52-week high reflect positive market sentiment, though UBS maintains a Neutral rating, noting a balanced risk/reward post-rally.

Analysis

United Natural Foods (UNFI) is experiencing a period of positive analyst revisions following a fourth-quarter 2025 earnings beat, where EPS of -$0.11 surpassed forecasts of -$0.16 and revenue of $7.7 billion slightly exceeded expectations. In response, UBS raised its price target to $42.00 and BMO Capital increased its target to $48.00. The company's operational strength is a key driver, demonstrated by better-than-anticipated customer retention, resilience following a recent cyber attack, and progress on productivity initiatives that have improved profitability and free cash flow, leading to accelerated debt reduction. However, analyst sentiment is not uniformly bullish; while BMO maintains an 'Outperform' rating, UBS holds a 'Neutral' stance. This divergence stems from valuation concerns, with UBS citing a 'more balanced risk/reward' after the stock's 71.31% one-year rally has brought it near its 52-week high. Furthermore, a known headwind is the planned exit of a large customer, which is expected to negatively impact top-line growth in fiscal 2026, though analysts anticipate this will be accretive to profitability.

Key Decisions for Investors

• Given the stock's 71.31% appreciation over the past year and its proximity to the 52-week high, investors should weigh the positive fundamental momentum against the more balanced risk/reward profile highlighted by UBS.
• Monitor the execution of the planned exit of a major customer in FY26, as the company's ability to offset the revenue impact while realizing the expected margin benefits will be a critical performance driver.
• Note the divergence in analyst ratings; while the upward revisions to EBITDA forecasts by both UBS and BMO are bullish, the 'Neutral' rating from UBS suggests potential investors may want to await a more favorable entry point rather than chasing the recent rally.